Stephen A Hill's Net Worth
Stephen A Hill's net worth is estimated to be at least $144,519.82 as of 11/23/2024. CoreStreet's estimation of Stephen A Hill's net worth is based on their sale of stock and current holding of stock.
Stephen A Hill is Director at Cellectar Biosciences Inc. They have executed at least 6 trades of stock as per SEC Form 4 filings. Their most recent trade was for 18,000 units of CLRB stock on 06/04/2020. Their biggest sale was on 12/29/2017 when they sold 1,250 units of Lipocine Inc stock for $4,337.50. They typically trade 1 times per year.
Total value of insider buys:
- $137,990.00
Total value of insider sells:
- $6,529.82
Most recent insider trade:
- June 4, 2020
Stephen A Hill's Insider Trading History
| Cellectar Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 4, 2020 | Director | 18,000 | $1.08 | Buy | $19,440.00 |
Nov. 29, 2018 | Director | 992 | $2.21 | Sell | $2,192.32 |
| Lipocine Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 29, 2017 | Director | 1,250 | $3.47 | Sell | $4,337.50 |
Nov. 13, 2014 | Director | 4,000 | $4.95 | Buy | $19,800.00 |
| Catalyst Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 17, 2015 | Director | 5,000 | $2.03 | Buy | $10,150.00 |
March 11, 2013 | CEO | 20,000 | $4.43 | Buy | $88,600.00 |